Right now, about half of all people who take medicine for an anxiety disorder don't get much help from it. And doctors have no definitive way to predict who will, and who won't, benefit from each antianxiety prescription they write.
But in a recently published study and a new clinical trial, scientists are working to bring more certainty to anxiety treatment, by probing the connection between brain activity, genetics and medication.